Resmed Inc (RMD) Inventory Turnover Ratio, from fourth quarter 2026 to fourth quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Resmed Inc   (NYSE: RMD)
 

Resmed Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Resmed Inc inventory turnover ratio, the Resmed Inc 's ability to sell and replace its inventory in the fourth quarter 2026, sequentially increased to 2.33 in the fourth quarter 2026, yet the ratio remained below the average, as RMD's market remain challenging.Average inventory processing period, for the Resmed Inc in Jun 30 2026 quarter, has decreased to 157 days, compare to 162 days, in the Mar 31 2026 quarter.

Within Healthcare sector 132 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the IV Quarter 2026, to 1479, from total ranking in the third quarter 2026 at 1595.

RMD Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Resmed Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RMD Inventory Turnover Ratio (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Inventory Growth 1.95 % 5.71 % 12.83 % 3.03 % 12.83 %
Y / Y Cost of Sales Growth 15.85 % 2.9 % 2.49 % 1.4 % 3.79 %
Inventory Turnover Ratio (TTM) 2.33 2.26 2.27 2.32 2.33
RMD's Total Ranking # 1479 # 1595 # 1491 # 1486 # 1470
Average inventory processing period 156 162 161 157 156
Seq. Inventory Growth 3.72 % -1.71 % -1.91 % 1.95 % 7.54 %
Seq. Cost of Sales Growth 13.24 % -0.75 % 5.93 % -2.69 % 0.58 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 53
Healthcare Sector # 133
Overall Market # 1479

Inventory Turnover Ratio Statistics
High Average Low
5.91 3.29 1.9
(Sep 30 2021)   (Jun 30 2023)



RMD Company Profile >> Back to RMD Efficiency Comparisons >> Compare RMD Inventory Turnover Ratio to its Competitors

Financial Statements
Resmed Inc 's Inventories $ 946 Millions Visit RMD's Balance sheet
Resmed Inc 's Cost of Revenues TTM $ 2,176 Millions Visit RMD's Income Statement
What are RMD's Sales? Visit RMD's Sales by Segment

Other Inventory Turnover Ratios
Resmed Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RMD's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RMD's Competitors
Inventory Turnover Ratio for RMD's Suppliers
Inventory Turnover Ratio for RMD's Customers

You may also want to know
RMD's Sales Growth Rates RMD's Pe Price to earnings ratio RMD's Receivables Turnover Ratio RMD's Stock Quote
RMD's Net Income Growth Rates RMD's Ps Price to Sales ratio RMD's Sales per Employee RMD's Asset Turnover Ratio
RMD's Net Margin RMD's Pb Price to Book ratio RMD's Financial Strength Ratios RMD's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions

Date modified: 2026-09-05T12:43:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.